Relationship between Patient Income Level and Mitral Valve Repair Utilization
Background: The superiority of mitral valve (MV) repair is well established with respect to long-term survival, preservation of ventricular function, and valve-related complications. The relationship between patient income level and the selection of MV procedure (repair versus replacement) has not been studied.
Methods: The 2005 to 2007 Nationwide Inpatient Sample database was searched for patients ? 30 years old with MV repair or replacement; patients with ischemic and congenital MV disease were excluded. Patients were stratified into quartiles according to income level (quartile 1, lowest; quartile 4, highest). We used univariate and multivariate models to compare patients with respect to baseline characteristics, selection of MV procedure, and hospital mortality.
Results: The preoperative profiles of the income quartiles differed significantly, with more risk factors occurring in the lower income quartiles. Unadjusted hospital mortality decreased with increasing income quartile. The percentage of patients receiving MV repair increased with increasing income (35.6%, 39.6%, 48.2%, and 55.8% for quartiles 1, 2, 3, and 4, respectively; P = .0001). Following adjustment for age, race, sex, urban residency, admission status, primary payer, Charlson comorbidity index, and hospital location and teaching status, the income quartiles had similar hospital death rates, whereas the highly significant relationship between valve repair and income level persisted (P = .0008).
Conclusions: Significant disparity exists among patients in the different income quartiles with respect to the likelihood of receiving MV repair. MV repair is performed less frequently in patients with lower incomes, even after adjustment for differences in baseline characteristics. The higher unadjusted mortality rate for less affluent patients appears mostly related to their worse preoperative profiles.
Agabiti N, Cesaroni G, Picciotto S, et al. 2008. The association of socioeconomic disadvantage with postoperative complications after major elective cardiovascular surgery. J Epidemiol Community Health 62:882-9.nAlter DA, Naylor CD, Austin P, Tu JV. 1999. Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med 341:1359-67.nBagger JP, Edwards MB, Taylor KM. 2008. Influence of socioeconomic status on survival after primary aortic or mitral valve replacement. Heart 94:182-5.nBirkmeyer NJ, Gu N, Baser O, Morris AM, Birkmeyer JD. 2008. Socioeconomic status and surgical mortality in the elderly. Med Care 46:893-9.nBoscarino JA, Chang J. 1999. Survival after coronary artery bypass graft surgery and community socioeconomic status: clinical and research implications. Med Care 37:210-6.nChang WC, Kaul P, Westerhout CM, Graham MM, Armstrong PW. 2007. Effects of socioeconomic status on mortality after acute myocardial infarction. Am J Med 120:33-9.nCharlson ME, Pompei P, Ales KL, MacKenzie CR. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-83.nClark AM, Duncan AS, Trevoy JE, Heath S, Chan M. 2010. Healthy diet in Canadians of low socioeconomic status with coronary heart disease: not just a matter of knowledge and choice. Heart Lung 40:156-63.nD'Hoore W, Bouckaert A, Tilquin C. 1996. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol 49:1429-33.nDeyo RA, Cherkin DC, Ciol MA. 1992. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613-9.nDuncan GJ, Daly MC, McDonough P, Williams DR. 2002. Optimal indicators of socioeconomic status for health research. Am J Public Health 92:1151-7.nFreed LA, Levy D, Levine RA, et al. 1999. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 341:1-7.nGillinov AM, Cosgrove DM 3rd. 2003. Current status of mitral valve repair. Am Heart Hosp J 1:47-54.nGrossi EA, Galloway AC, Miller JS, et al. 1998. Valve repair versus replacement for mitral insufficiency: when is a mechanical valve still indicated? J Thorac Cardiovasc Surg 115:389-94; discussion 394-6.nHardy D, Liu CC, Xia R, et al. 2009. Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer. Cancer 115:2199-211.nHCUP (Healthcare Cost and Utilization Project). 2010. Overview of the Nationwide Inpatient Sample (NIS). Available at: http://www.hcup-us.ahrq.gov/nisoverview.jsp'>http://www.hcup-us.ahrq.gov/nisoverview.jspnHCUP quality control procedures. 2008. Available at: http://www.hcup-us.ahrq.gov/db/quality.pdf'>http://www.hcup-us.ahrq.gov/db/quality.pdfnJones EC, Devereux RB, Roman MJ, et al. 2001. Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study). Am J Cardiol 87:298-304.nPerier P, Deloche A, Chauvaud S, et al. 1984. Comparative evaluation of mitral valve repair and replacement with Starr, Bjork, and porcine valve prostheses. Circulation 70(pt 2):I187-92.nPhilbin EF, McCullough PA, DiSalvo TG, Dec GW, Jenkins PL, Weaver WD. 2000. Socioeconomic status is an important determinant of the use of invasive procedures after acute myocardial infarction in New York State. Circulation 102(suppl 3):III107-15.nPilote L, Tu JV, Humphries K, et al. 2007. Socioeconomic status, access to health care, and outcomes after acute myocardial infarction in Canada's universal health care system. Med Care 45:638-46.nSchermerhorn ML, Giles KA, Hamdan AD, Dalhberg SE, Hagberg R, Pomposelli F. 2008. Population-based outcomes of open descending thoracic aortic aneurysm repair. J Vasc Surg 48:821-7.nSingh JP, Evans JC, Levy D, et al. 1999. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 83:897-902.nVassileva CM, Boley T, Markwell S, Hazelrigg S. 2012. Impact of hospital annual mitral volume on mitral valve repair rates and mortality. J Heart Valve Dis 21:41-7.nVassileva CM, Markwell S, Boley T, Hazelrigg S. 2011. Impact of race on mitral procedure selection and short-term outcomes of patients undergoing mitral valve surgery. Heart Surg Forum 14:E221-6.nVassileva CM, Stelle LM, Markwell S, Boley T, Hazelrigg S. 2011. Sex differences in procedure selection and outcomes of patients undergoing mitral valve surgery. Heart Surg Forum 14:E276-82.nWenneker MB, Weissman JS, Epstein AM. 1990. The association of payer with utilization of cardiac procedures in Massachusetts. JAMA 264:1255-60.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).